ClinicalTrials.govpublic full text
Vaccine Enriched, Autologous, Activated T-Cells Directed to Tumor in Patients With Relapsed/Refractory Melanoma
melanoma, metastatic, relapsed, refractory, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 912525
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.